中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
8期
256-257
,共2页
史恩红%高韵%姜海微%孙静薇
史恩紅%高韻%薑海微%孫靜薇
사은홍%고운%강해미%손정미
奥施康定%超声电导仪%癌痛
奧施康定%超聲電導儀%癌痛
오시강정%초성전도의%암통
Oxycontin%Ultras ound conductimeter therapy%Cancer pain
目的：探讨盐酸羟考酮缓释片（奥施康定）联合超声电导仪治疗中重度癌痛的疗效、不良反应。方法选取2012年6月～2014年11月我院收治的中重度晚期癌痛患者80例，将其随机分为两组：对照组（40例）患者给予奥施康定治疗，起始剂量10 mg/次，1次/12 h，口服；观察组（40例）患者在口服奥施康定治疗的同时，配合疼痛部位应用超声电导仪治疗。两组均根据疼痛缓解情况调整奥施康定的剂量，直至将疼痛缓解至患者满意的程度。30 d后评价两组患者的疼痛缓解度，比较不良反应发生率。结果两组均能有效地控制癌痛，治疗组与对照组疼痛缓解率无统计学意义（P>0.05），分别为97.5%和92.5%；而治疗组不良反应发生率明显低于对照组，差异有统计学意义（P<0.05）。结论中重度癌痛患者口服奥施康定治疗过程中配合超声电导仪治疗，能有效控制中重度癌痛，可以减少羟考酮控释片的不良反应，提高患者的生活质量。
目的：探討鹽痠羥攷酮緩釋片（奧施康定）聯閤超聲電導儀治療中重度癌痛的療效、不良反應。方法選取2012年6月～2014年11月我院收治的中重度晚期癌痛患者80例，將其隨機分為兩組：對照組（40例）患者給予奧施康定治療，起始劑量10 mg/次，1次/12 h，口服；觀察組（40例）患者在口服奧施康定治療的同時，配閤疼痛部位應用超聲電導儀治療。兩組均根據疼痛緩解情況調整奧施康定的劑量，直至將疼痛緩解至患者滿意的程度。30 d後評價兩組患者的疼痛緩解度，比較不良反應髮生率。結果兩組均能有效地控製癌痛，治療組與對照組疼痛緩解率無統計學意義（P>0.05），分彆為97.5%和92.5%；而治療組不良反應髮生率明顯低于對照組，差異有統計學意義（P<0.05）。結論中重度癌痛患者口服奧施康定治療過程中配閤超聲電導儀治療，能有效控製中重度癌痛，可以減少羥攷酮控釋片的不良反應，提高患者的生活質量。
목적：탐토염산간고동완석편（오시강정）연합초성전도의치료중중도암통적료효、불량반응。방법선취2012년6월～2014년11월아원수치적중중도만기암통환자80례，장기수궤분위량조：대조조（40례）환자급여오시강정치료，기시제량10 mg/차，1차/12 h，구복；관찰조（40례）환자재구복오시강정치료적동시，배합동통부위응용초성전도의치료。량조균근거동통완해정황조정오시강정적제량，직지장동통완해지환자만의적정도。30 d후평개량조환자적동통완해도，비교불량반응발생솔。결과량조균능유효지공제암통，치료조여대조조동통완해솔무통계학의의（P>0.05），분별위97.5%화92.5%；이치료조불량반응발생솔명현저우대조조，차이유통계학의의（P<0.05）。결론중중도암통환자구복오시강정치료과정중배합초성전도의치료，능유효공제중중도암통，가이감소간고동공석편적불량반응，제고환자적생활질량。
Objective To investigate the curative effects,adverse reactions of oxycodone hydrochloride tab-lets(Oxycontin)combined with the ultras ound conductimeter therapy in treatment of moderate or severe cancer pain.MethodsA total of 80 patients who were admitted to our hospital from June 2012 to November 2014 were randomly divided into two groups: control group were treated with oxycontin; observation group were treated with oxycontin and the ultras ound conductimeter therapy; in both groups,the dose of oxycontin was adjusted according to pain relief degree until the patients felt satisfied. After 30 days,pain relief degree of two groups was evaluated,adverse reaction incidences were compared between two groups.ResultsControl rates of cancer pain were similar in both two groups. However,incidence rate of adverse effects in the observation group,was significant lower than in the control group.Conclusion Oxycodone combined with ultras ound conductimeter therapy may relieve the pain of moderate to severe lung cancer and hence reduce adverse effects of oxycodone,which in turn improves the quality of life of the patients.
